Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spectrum Pharmaceuticals, Inc. - Common Stock (NQ: SPPI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LIVE, SLQT and SPPI
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
SPPI ALERT: Investors With Substantial Losses Have Opportunity to Lead the Spectrum Pharmaceuticals, Inc. Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
From The Rosen Law Firm, P.A.
Via Business Wire
Have You Lost Money Investing In Spectrum Pharmaceuticals? Securities Class Action Investigation -SPPI Investors Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C.
PHILADELPHIA, PA / ACCESSWIRE / September 1, 2021 / Kehoe Law Firm, P.C. is investigating whether Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ:SPPI) violated federal securities... 
From Kehoe Law Firm, P.C.
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (... 
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Notice: Investigation over Possible Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 08/17/2021 -- Spectrum Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Stocks That Hit 52-Week Lows On Friday
Friday morning, 94 companies reached new 52-week lows. Significant Points: Wix.com (NASDAQ:WIX) is the largest company in terms of market cap to set a new 52-week... 
Via Benzinga
Spectrum Pharmaceuticals, inc (SPPI) Q2 2021 Earnings Call Transcript
SPPI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Spectrum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, Inc. on Behalf of Spectrum Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet
Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 20.59% to $3.08 during Friday's regular session. The current volume of 16.2 million shares is 348.19% of SCWorx... 
Via Benzinga
Why Spectrum Pharmaceuticals Stock Is Crashing Today
The company received a thumbs-down from the FDA for its lead pipeline candidate. 
Via The Motley Fool
Exposures Product Safety
Mid-Morning Market Update: Markets Mostly Higher; US Economy Adds 943,000 Jobs
Following the market opening Friday, the Dow traded up 0.37% to 35,193.61 while the NASDAQ fell 0.26% to 14,857.09. The S&P also rose, gaining 0.16% to 4,436.02. The U.S. has... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
55 Stocks Moving In Friday's Mid-Day Session
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a... 
Via Benzinga
Spectrum Pharma Stock Craters As FDA Slaps Response Letter For Its Neutropenia Candidate
Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) has received an FDA Complete Response Letter (CRL) regarding its marketing application for Rolontis (eflapegrastim) for... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1.... 
Via Benzinga
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
From Spectrum Pharmaceuticals
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.